RESEARCH HIGHLIGHTS
Cancer biology Aggravating tumor aggressiveness
A protein secreted from breast cancer cells enhances the spread and survival of tumor cells
Proteins associated with enhanced tumor aggressiveness could be potential therapeutic targets to fight cancer. An international team of researchers led by Edison Liu at the A*STAR Genome Institute of Singapore has now discovered that serine protease inhibitor Kazal-type 1 (SPINK1), a secreted protein, plays a key role in tumor aggressiveness in breast cancer1
.
Researchers have been seeking novel molecular targets for antibody-based and molecule-based drugs treatments for breast cancer in order to combat the cancer’s increased resistance to common drug treatments. In their search for factors that correlate with poor patient survival, Liu and his co-workers performed a whole-genome analysis on four groups comprising 800 breast cancer patients. They were looking for possible drug targets, such as cell surface receptors, secreted growth factors, and genes encoded with extracellular proteins. The analysis turned up SPINK1, a secreted protein linked
to the recurrence of cancer spread in all of the patient groups. Extending this analysis to publicly available data for breast cancer patients in ten other studies, Liu and his team were able to confirm the link between SPINK1 expression and poor prognosis in eight of these studies. SPINK1 is a protein commonly expressed in digestive organs
and tissues, such as the pancreas, where its primary role is the inhibition of digestive enzymes. SPINK1 is not expressed in normal human breast tissue, but Liu’s team found that it was present in breast tumors (see image). In cell culture experiments, the researchers showed that
reducing the expression of SPINK1 in breast cancer cells normally expressing high levels of the protein in turn reduces cancer cell survival. Increasing SPINK1 levels in breast cancer cells, on the other hand, confers drug resistance to the cancer cells. Liu links his findings to a drop in the expression of proteins that mediate cell death, and an increase in the expression of proteins that keep cells alive. Enhancing the expression of SPINK1 in breast cancer cells in mice accelerated the migration of cancer cells and increased tumor spread. The researchers argue that this could account for the link between SPINK1 expression and cancer recurrence in
A*STAR RESEARCH OCTOBER 2011– MARCH 2012
Microscopy image showing SPINK1 expression (brown) in breast tis- sue. SPINK1 is highly expressed in breast tumor tissue (green arrow) but not in adjacent normal breast tissue (red arrow).
their patient groups, and are currently seeking to identify the receptor through which SPINK1 acts. “SPINK1 has already been implicated in prostate cancer,” explains Liu, “but our work generalizes the importance of this molecule to the virulence of breast cancers as well.” The findings suggest that blocking the expression or activity of SPINK1 in breast cancer cells could be a potential therapy for breast cancer.
■
1. Soon, W. W. et al. Combined genomic and phenotype screening reveals secretory factor SPINK1 as an invasion and survival factor associated with patient prognosis in breast cancer. EMBO Molecular Medicine 3, 451–464 (2011).
33
© 2011 EMBO
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96